At the forefront of cardiovascular innovation, Drug-Eluting Stents (DES) have become the standard of care for treating blocked coronary arteries, especially in high-risk populations like diabetics.

A drug-eluting stent, or DES, is a small, metal mesh tube placed in a blocked coronary artery.The metal is coated in medicine and helps reopen your artery and keep it open. ‌ Stents are used to ...

Drug-eluting stents prevent restenosis by inhibiting the proliferation of smooth muscle cells that cause neointimal thickening. They accomplish this by slowly releasing potent antiproliferative ...

Drug-eluting stents are a great option for people with one or two narrowed coronary arteries, but they’re only one part of the solution. You may also need to take statins, ...

Drug-eluting stents (DES) result in a small but significant increase in late and very late stent thrombosis compared with bare-metal stents.

Drug-eluting stents with controlled local release of antiproliferative agents have consistently reduced the risk of repeat revascularization, as compared with bare-metal stents. 5–7 However, a ...

A drug-eluting stent is a device used in operations to treat coronary artery disease. It is usually inserted during balloon angioplasty, in patients who have suffered a heart attack or who have ...

Covina, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Drug Eluting Stent Market accounted for US$ 7.5 billion in 2022 and is estimated to be US$ 14.02 billion by 2032 and is anticipated to register a CAGR of ...

Diabetes mellitus is highly prevalent in patients with coronary atherosclerosis. As a result of several factors, including a ...

Conclusion The Argentina Coronary Stents Market presents lucrative growth opportunities driven by advancements in medical technology and increasing prevalence of cardiovascular diseases. This report ...

The TRANSFORM II trial, led by Bernardo Cortese, MD, has reached full patient enrollment. This investigation compares the MagicTouch Sirolimus-Coated Balloon to everolimus-eluting stents. Aimed at ...

DES: Drug-eluting stent. Reproduced with permission from [ 25 ] . The Indian manufacturer Sahajanand (Gujarat, India) presented initial results of their bioabsorbable polymer platform – the ...